{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:42:21Z","timestamp":1792755741654,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002619","name":"Ajou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A2B6004598"],"award-info":[{"award-number":["NRF-2018R1A2B6004598"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2012R1A5A2048183"],"award-info":[{"award-number":["NRF-2012R1A5A2048183"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B03031468"],"award-info":[{"award-number":["NRF-2017R1D1A1B03031468"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.phrs.2019.104281","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T12:04:15Z","timestamp":1558440255000},"page":"104281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine \u03b3-lyase protein degradation"],"prefix":"10.1016","volume":"146","author":[{"given":"Zhexi","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Eun","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjeong","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Anh T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonbeom","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan E.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.104281_bib0005","series-title":"A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis","author":"World Health Organization (WHO)","year":"2013"},{"key":"10.1016\/j.phrs.2019.104281_bib0010","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJMsa0903829","article-title":"The hypertension paradox--more uncontrolled disease despite improved therapy","volume":"361","author":"Chobanian","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2019.104281_bib0015","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm.2541","article-title":"Under pressure: the search for the essential mechanisms of hypertension","volume":"17","author":"Coffman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2019.104281_bib0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/physrev.00007.2009","article-title":"Sympathetic nervous system overactivity and its role in the development of cardiovascular disease","volume":"90","author":"Malpas","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2019.104281_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2017.05.020","article-title":"Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease","volume":"125","author":"Ferrario","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104281_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11906-018-0808-8","article-title":"The interactions of the immune system and the brain in hypertension","volume":"20","author":"Perrotta","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.phrs.2019.104281_bib0035","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCRESAHA.114.300505","article-title":"Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease","volume":"114","author":"Polhemus","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2019.104281_bib0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2019.104281_bib0045","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbapap.2014.01.002","article-title":"H2S and its role in redox signaling","volume":"1844","author":"Kabil","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104281_bib0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrm3391","article-title":"H2S signalling through protein sulfhydration and beyond","volume":"13","author":"Paul","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2019.104281_bib0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1162667","article-title":"H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase","volume":"322","author":"Yang","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104281_bib0060","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","article-title":"Hydrogen sulfide is an endogenous stimulator of angiogenesis","volume":"106","author":"Papapetropoulos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104281_bib0065","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.113.002208","article-title":"Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis","volume":"127","author":"Mani","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.104281_bib0070","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tips.2015.05.007","article-title":"The role of H2S bioavailability in endothelial dysfunction","volume":"36","author":"Wang","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2019.104281_bib0075","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/HYPERTENSIONAHA.116.08964","article-title":"Impaired hydrogen sulfide-mediated vasodilation contributes to microvascular endothelial dysfunction in hypertensive adults","volume":"69","author":"Greaney","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2019.104281_bib0080","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","article-title":"Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation","volume":"109","author":"Coletta","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104281_bib0085","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41598-017-04874-4","article-title":"HDAC6: a novel histone deacetylase implicated in pulmonary arterial hypertension","volume":"7","author":"Boucherat","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2019.104281_bib0090","doi-asserted-by":"crossref","first-page":"H252","DOI":"10.1152\/ajpheart.00149.2014","article-title":"HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling","volume":"307","author":"Demos-Davies","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2019.104281_bib0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2011.04.005","article-title":"Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension","volume":"51","author":"Lemon","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2019.104281_bib0100","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jcmm.14188","article-title":"Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension","volume":"23","author":"Choi","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2019.104281_bib0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104281_bib0110","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.phrs.2019.104281_bib0115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2019.104281_bib0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"HDAC6 modulates cell motility by altering the acetylation level of cortactin","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2019.104281_bib0125","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","article-title":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney","volume":"103","author":"Crowley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104281_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vph.2005.01.006","article-title":"Angiotensin II-induced hypertension in mice caused an increase in insulin secretion","volume":"42","author":"Gletsu","year":"2005","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104281_bib0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vph.2015.04.006","article-title":"Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes","volume":"72","author":"Choi","year":"2015","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104281_bib0140","doi-asserted-by":"crossref","first-page":"H711","DOI":"10.1152\/ajpheart.00724.2016","article-title":"Cystathionine gamma-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6","volume":"312","author":"Leucker","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2019.104281_bib0145","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2019.104281_bib0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ab.2012.01.001","article-title":"Enhanced detection of hydrogen sulfide generated in cell culture using an agar trap method","volume":"423","author":"Kartha","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.phrs.2019.104281_bib0155","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1074\/jbc.M112.410126","article-title":"Phosphatidylinositol 4-phosphate 5-kinase alpha facilitates Toll-like receptor 4-mediated microglial inflammation through regulation of the Toll\/interleukin-1 receptor domain-containing adaptor protein (TIRAP) location","volume":"288","author":"Nguyen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104281_bib0160","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.bbamcr.2015.07.001","article-title":"Phosphorylation of phosphatidylinositol 4-phosphate 5-kinase gamma by Akt regulates its interaction with talin and focal adhesion dynamics","volume":"1853","author":"Le","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104281_bib0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cellsig.2017.07.009","article-title":"Phosphatidylinositol 4-phosphate 5-kinase alpha contributes to Toll-like receptor 2-mediated immune responses in microglial cells stimulated with lipoteichoic acid","volume":"38","author":"Nguyen","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2019.104281_bib0170","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/onc.2015.293","article-title":"PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition","volume":"35","author":"Meng","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2019.104281_bib0175","doi-asserted-by":"crossref","first-page":"22211","DOI":"10.1074\/jbc.M110.180224","article-title":"Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells","volume":"286","author":"Huber","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104281_bib0180","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.lfs.2008.03.004","article-title":"The use of diversity profiling to characterize chemical modulators of the histone deacetylases","volume":"82","author":"Blackwell","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2019.104281_bib0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/biof.1032","article-title":"Sirtuin activators and inhibitors","volume":"38","author":"Villalba","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.phrs.2019.104281_bib0190","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1074\/jbc.M113.511444","article-title":"Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase\/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1","volume":"289","author":"Kumar","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104281_bib0195","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","article-title":"Inside HDAC with HDAC inhibitors","volume":"45","author":"Bertrand","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2019.104281_bib0200","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2015.05.006","article-title":"Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response","volume":"59","author":"Elia","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2019.104281_bib0205","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/ars.2013.5309","article-title":"Production and physiological effects of hydrogen sulfide","volume":"20","author":"Kimura","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2019.104281_bib0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2017.12.005","article-title":"Hydrogen sulfide as a regulatory factor in kidney health and disease","volume":"149","author":"Kasinath","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104281_bib0215","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1517\/14728222.2012.673591","article-title":"Hydrogen sulfide as a therapeutic target for inflammation","volume":"16","author":"Rivers","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.phrs.2019.104281_bib0220","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1873962","article-title":"Antioxidant and cell-signaling functions of hydrogen sulfide in the central nervous system","volume":"2018","author":"Shefa","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2019.104281_bib0225","doi-asserted-by":"crossref","first-page":"19626","DOI":"10.1038\/srep19626","article-title":"Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of alpha-tubulin acetylation and FGF-21 up-regulation","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2019.104281_bib0230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2016.06.001","article-title":"HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma","volume":"379","author":"Wang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2019.104281_bib0235","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1042\/CS20160084","article-title":"The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease","volume":"130","author":"Batchu","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.phrs.2019.104281_bib0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2019.104281_bib0245","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biochi.2007.06.009","article-title":"Regulation of protein turnover by acetyltransferases and deacetylases","volume":"90","author":"Sadoul","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.phrs.2019.104281_bib0250","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/onc.2015.214","article-title":"Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer","volume":"35","author":"Chang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2019.104281_bib0255","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1038\/onc.2015.476","article-title":"Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2019.104281_bib0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molcel.2014.04.028","article-title":"HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSalpha","volume":"55","author":"Zhang","year":"2014","journal-title":"Mol. Cell"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819302488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819302488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:31:17Z","timestamp":1778581877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819302488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":52,"alternative-id":["S1043661819302488"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104281","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine \u03b3-lyase protein degradation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104281"}}